International Journal of Medicine and Public Health,
Journal Year:
2022,
Volume and Issue:
12(2), P. 50 - 55
Published: April 29, 2022
International
Journal
of
Medicine
and
Public
Health,2022,12,2,50-55.DOI:10.5530/ijmedph.2022.2.11Published:April
2022Type:Review
ArticleScientometric
Mapping
Mucormycosis
Research
in
Relation
to
the
COVID-19
PandemicDevi
Dayal,
Brij
Mohan
Gupta,
Mallikarjun
Kappi
Devi
Dayal1,*,
Gupta2,
Kappi3
1Department
Pediatrics,
Postgraduate
Institute
Medical
Education
Research,
Chandigarh.
INDIA.
2Formerly
with
CSIR-National
Science,
Technology
Development
Studies,
New
Delhi,
3Government
First
Grade
College,
Jagalur,
Davanagere
University,
Davanagere,
Karnataka,
Abstract:Background:
is
an
invasive
fungal
infection
that
has
shown
a
surge
during
pandemic.
A
comprehensive
assessment
associated
mucormycosis
(CAM)
research
lacking.
Methods:
We
searched
Elsevier’s
Scopus
database
for
publications
on
CAM
using
pre-defined
search
strategy.
Data
numbers,
citation
metrics,
contributing
countries,
institutions,
authors,
journals,
most
cited
articles
were
analyzed
select
bibliometric
tools.
Results:
Published
included
253
publications.
These
1560
times,
averaging
6.1
citations
per
paper.
Only
33
(13%)
funded.
Original
(55.7%)
reviews
(17.7%)
constituted
major
share
global
output.
The
studied
age
groups
adults
(22.5%),
middle-aged
(19.3%),
elderly
(10.6%),
adolescents
(0.8%).
Studies
treatment
accounted
largest
(58.5%),
followed
by
clinical
studies
(28.0%),
complications
(17.3%),
risk
factors
(11.7%),
epidemiology
(7.9%),
pathophysiology
(3.1%).
participating
countries
64;
India,
USA,
Egypt
led
productivity,
whereas
France,
Iran
more
impactful.
Of
84
organizations,
leading
organizations
PGIMER-Chandigarh,
AIIMS-New
Delhi
Cairo
Egypt.
A.
Chakrabarti,
V.
Muthu,
S.M.
Rudramurthy
productive
160
authors.
Indian
Ophthalmology,
Otolaryngology
Head
Neck
Surgery,
Fungi
active
journals
published
research.
Conclusion:
primarily
been
conducted
middleincome
low
quality.
High-income
need
collaborate
lowand
middle-income
sustainable
universal
impact.
There
also
focus
gaps
such
as
future
Keywords:Bibliometrics,
CAM,
Coronavirus
disease
2019,
mucormycosis,
Fungal
infectionsView:PDF
(160.79
KB)
Viruses,
Journal Year:
2023,
Volume and Issue:
15(1), P. 175 - 175
Published: Jan. 7, 2023
The
clinical
course
and
outcome
of
COVID-19
are
highly
variable,
ranging
from
asymptomatic
infections
to
severe
disease
death.
Understanding
the
risk
factors
is
relevant
both
in
setting
at
epidemiological
level.
Here,
we
provide
an
overview
host,
viral
environmental
that
have
been
shown
or
(in
some
cases)
hypothesized
be
associated
with
outcomes.
considered
detail
include
age
frailty,
genetic
polymorphisms,
biological
sex
(and
pregnancy),
co-
superinfections,
non-communicable
comorbidities,
immunological
history,
microbiota,
lifestyle
patient;
variation
infecting
dose;
socioeconomic
factors;
air
pollution.
For
each
category,
compile
(sometimes
conflicting)
evidence
for
association
factor
outcomes
(including
strength
effect)
outline
possible
action
mechanisms.
We
also
discuss
complex
interactions
between
various
factors.
Antibiotics,
Journal Year:
2022,
Volume and Issue:
11(3), P. 315 - 315
Published: Feb. 25, 2022
The
outbreak
of
COVID-19
has
significantly
changed
the
epidemiology
respiratory
tract
infection
in
several
ways.
implementation
non-pharmaceutical
interventions
(NPIs)
including
universal
masking,
hand
hygiene,
and
social
distancing
not
only
resulted
a
decline
reported
SARS-CoV-2
cases
but
also
contributed
to
non-COVID-19
infection-related
hospital
utilization.
Moreover,
it
led
decreased
incidence
previous
commonly
encountered
pathogens,
such
as
influenza
Streptococcus
pneumoniae.
Although
antimicrobial
agents
are
essential
for
treating
patients
with
co-infection,
prescribing
antibiotics
was
higher
than
estimated
prevalence
bacterial
which
indicated
overuse
or
unnecessary
antibiotic
use
during
pandemic.
Furthermore,
inappropriate
exposure
may
drive
selection
drug-resistant
microorganisms,
disruption
control
setting
measures
result
spread
multidrug-resistant
organisms
(MDROs).
In
conclusion,
NPIs
could
be
effective
preventing
changing
microbiologic
distribution
pathogens;
however,
we
should
continue
epidemiological
surveillance
establish
updated
information,
stewardship
programs
appropriate
antibiotic,
prevention
prevent
MDROs
Brazilian Journal of Medical and Biological Research,
Journal Year:
2025,
Volume and Issue:
58
Published: Jan. 1, 2025
The
COVID-19
pandemic
has
caused
a
global
crisis,
overwhelming
hospitals
and
intensive
care
units
(ICU)
leading
to
an
increase
in
nosocomial
infections
due
prolonged
hospitalization
other
risk
factors.
present
study
evaluated
the
prevalence
of
secondary
fungal
critically
ill
patients
with
COVID-19.
This
is
retrospective,
single-center
conducted
hospital
northeastern
Brazil,
which
1,364
medical
records
admitted
ICU
during
2020
2021.
A
total
327
pathogenic
yeasts
were
isolated
from
132
(40.4%)
respiratory,
70
(21.4%)
blood,
124
(37.9%)
urine,
one
(0.3%)
surgical
wound
samples.
Fungal
diagnosed
intermediate
(5
12
days)
or
late
(≥12
stage
hospitalization.
most
frequent
yeast
was
Candida
albicans
[126
(67.7%)
60
(42.6%)],
followed
by
tropicalis
[25
(13.4%)
39
(27.7%)].
parapsilosis
isolates
increased
5.7-fold
2021
[40
(28.4%)]
compared
[7
(3.8%)].
least
frequently
Nakaseomyces
glabratus
[4
(2.2%)
1
(0.7%)],
Pichia
kudriavzevii,
only
(1
(0.7%)).
During
period,
decrease
susceptibility
antifungals
observed:
voriconazole
reduced
100
77.2%,
flucytosine
99.4
78.8%,
micafungin
83.6%.
changes
frequency
species
causing
indicate
need
for
early
adequate
diagnosis
minimize
negative
outcomes.
Journal of Pathology and Translational Medicine,
Journal Year:
2023,
Volume and Issue:
57(1), P. 28 - 42
Published: Jan. 15, 2023
About
one-fourth
of
the
global
population
is
either
overweight
or
obese,
both
which
increase
risk
insulin
resistance,
cardiovascular
diseases,
and
infections.
In
obesity,
immune
cells
adipocytes
produce
an
excess
pro-inflammatory
cytokines
that
may
play
a
significant
role
in
disease
progression.
recent
coronavirus
2019
(COVID-19)
pandemic,
important
pathological
characteristics
such
as
involvement
renin-angiotensin-aldosterone
system,
endothelial
injury,
cytokine
release
have
been
shown
to
be
connected
with
obesity
associated
sequelae
resistance/type
2
diabetes
hypertension.
This
connection
explain
severity
COVID-19
patients
metabolic
disorders.
Many
studies
also
reported
association
between
type
persistent
viral
Similarly,
favors
growth
various
microorganisms
including
protozoal
pathogens
well
opportunistic
bacteria
fungi.
Furthermore,
factor
for
number
prion-like
diseases.
There
interesting
relationship
helminths
diabetes;
helminthiasis
reduce
state,
but
even
neoplastic
processes.
Several
documented
altered
circulating
levels
neutrophils,
lymphocytes,
monocytes
likely
modifies
vaccine
effectiveness.
Timely
monitoring
inflammatory
markers
(e.g.,
C-reactive
protein)
energy
homeostasis
leptin)
could
helpful
preventing
many
obesity-related
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 555 - 555
Published: Feb. 27, 2023
Coronavirus
disease
2019
(COVID-19)
infection
is
currently
a
great
cause
of
concern
for
the
healthcare
sector
around
globe.
SARS-CoV-2
an
RNA
virus
that
causes
serious
associated
with
numerous
adverse
effects
and
multiple
complications
different
organs
systems
during
its
pathogenic
cycle
in
humans.
Individuals
affected
by
COVID-19,
especially
elderly
populations
immunocompromised
people,
are
greatly
vulnerable
to
opportunistic
fungal
pathogens.
Aspergillosis,
invasive
candidiasis,
mucormycosis
widespread
coinfections
COVID-19
patients.
Other
infections
rare
but
exhibiting
increased
incidence
current
scenario
include
caused
Pneumocystis
jirovecii,
Histoplasma
sp.,
Cryptococcus
etc.
By
producing
virulent
spores,
these
pathogens
increase
severity
morbidity
fatality
rates
patients
globally.
These
generally
occur
recovering
from
infection,
resulting
rehospitalization.
Older
individuals
at
higher
risk
developing
infections.
This
review
focuses
on
understanding
prevalent
patients,
people.
We
have
also
highlighted
important
preventive
methods,
diagnostic
approaches,
prophylactic
measures
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
13
Published: Feb. 20, 2024
Background
Fungal
co-infection
is
prevalent
in
critically
ill
patients
with
COVID-19.
The
conventional
approach
applied
to
fungal
identification
has
relatively
low
sensitivity
and
time-consuming.
metagenomic
next-generation
sequencing
(mNGS)
technology
can
simultaneously
detect
a
variety
of
microorganisms,
increasingly
being
used
for
the
rapid
detection
diagnosis
pathogens.
Methods
In
this
single-center
retrospective
study,
we
described
clinical
presentation
outcomes
COVID-19
mNGS
positive
fungi
pulmonary
during
outbreak
Omicron
infection
from
December
2022
January
2023.
Results
Among
43
acute
respiratory
distress
syndrome
(ARDS)
on
single
intensive
care
unit
(ICU),
10
were
reported
be
using
test.
number
pathogenic
microorganisms
detected
by
was
significantly
higher
than
that
via
traditional
methods,
especially
viruses.
Aspergillus
dominant,
most
these
also
had
concurrent
bacterial
or
viral
infections.
Probable
possible
COVID-19-associated
aspergillosis
(CAPA)
diagnosed
all
patients,
prognosis
poor.
Conclusion
Patients
may
at
increased
risk
developing
infections
as
well
infections,
powerful
tool
identifying
Clinicians
should
aware
particularly
those
who
have
underlying
immunocompromising
conditions,
monitor
early
signs
infection.
Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 9, 2022
Secondary
fungal
infections
may
complicate
the
clinical
course
of
patients
affected
by
viral
respiratory
diseases,
especially
those
admitted
to
intensive
care
unit.
Hospitalized
COVID-19
are
at
increased
risk
co-infections
exacerbating
prognosis
disease
due
misdiagnosis
that
often
result
in
treatment
failure
and
high
mortality
rate.
COVID-19-associated
caused
predominantly
Aspergillus
Candida
species,
fungi
order
Mucorales
have
been
reported
from
several
countries
become
significant
challenge
for
healthcare
system.
Early
diagnosis
adequate
antifungal
therapy
is
essential
improve
outcomes,
however,
drug
resistance
shows
a
rising
trend
highlighting
need
alternative
therapeutic
agents.
The
purpose
this
review
summarize
current
knowledge
on
mycoses,
strategies
most
recent
advancements
development
focusing
peptides
with
activity.
PLoS ONE,
Journal Year:
2022,
Volume and Issue:
17(7), P. e0271333 - e0271333
Published: July 11, 2022
Objectives
This
systematic
review
aims
to
summarize
the
mycological
and
clinical
features
of
COVID-19-associated
fungal
infections
(CAFIs)
in
Iran.
Methods
PubMed,
Web
Science,
Scopus,
Cochrane
Library,
SID,
Magiran,
IranDoc,
Google
Scholar
were
searched
for
Persian
English
articles
published
from
January
1,
2020,
November
5,
2021,
using
a
search
strategy.
Studies
on
Iranian
patients
suffering
CAFIs
included
review.
Results
Twenty-two
studies
comprising
169
retrieved.
Reported
candidiasis
(85,
50.30%),
mucormycosis
(35,
20.71%),
aspergillosis
(29,
17.16%),
fusariosis
(6,
3.55%),
three
cases
caused
by
rare
pathogens
(Rhodotorula
mucilaginosa
,
Diaporthe
foeniculina
Sarocladium
kiliense
)
11
(6.51%)
uncharacterized
mold
infections.
The
most
common
underlying
diseases
diabetes
(67/168,
39.88%),
cardiovascular
(55/168,
32.74%),
hypertension
(43/168,
25.59%).
use
antibiotics
(111/124,
89.52%),
corticosteroids
(93/132,
70.44%),
mechanical
ventilation
(66,
51.16%)
predisposing
factors.
Totally,
72
(50.35%)
143
with
died
(data
not
available
26
patients).
Conclusion
Fungal
are
evident
be
complication
COVID-19
Iran;
thus,
clinicians
should
consider
them
as
differential
diagnosis,
especially
comorbidities
previous
antibiotic
or
corticosteroid
use.